|
Volumn 343, Issue 7824, 2011, Pages
|
Pfizer's reply to de monteverde-robb
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LORAZEPAM;
DRUG APPROVAL;
DRUG MANUFACTURE;
LETTER;
PRIORITY JOURNAL;
UNITED KINGDOM;
UNITED STATES;
HUMANS;
LORAZEPAM;
|
EID: 84859007060
PISSN: 09598146
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.d5962 Document Type: Letter |
Times cited : (1)
|
References (1)
|